Rather than simply blocking these enzymes, copper peptides promote the synthesis of tissue inhibitors of metalloproteinases (TIMPs), creating a balanced environment where old, damaged collagen is removed while new, healthy collagen is produced
Behind them, companies such as Amgen, Boehringer Ingelheim, Zealand Pharma, Viking Therapeutics, Roche, Pfizer, and AstraZeneca are building differentiated positions
Still no peptides
Maintaining a minimum of 1,800 calories daily, staying well hydrated with 80 to 100 ounces of fluid, and monitoring supply closely during the first few weeks of treatment minimizes this risk
To date, a multitude of genes associated with mitochondrial diseases have been identified in both genomes